Drug Type Small molecule drug |
Synonyms Becocalcidiol (USAN/INN), 2-MBISP, 2-MBP + [3] |
Target |
Action agonists |
Mechanism VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H36O2 |
InChIKeyQSLUXQQUPXBIHH-YHSKWIAJSA-N |
CAS Registry524067-21-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Plaque psoriasis | Phase 2 | United States | 01 Sep 2004 |
Phase 2 | - | Placebo | nqmuiuctpw(doadubvcor): P-Value = 0.002 | Positive | 01 Aug 2007 | ||
Becocalcidiol 75 microg g(-1) twice daily |





